BIOMAT Database Logo BIOMAT Database Logo

Risk of thrombogenicity among nonionic radiocontrast agents. 2008

Alexander Georgakis, and Rasih Atilla Ener, and Jianguo Jin, and Satya Kunapuli, and David Fiss, and Stephen H Leech, and Nelson M Wolf, and William A Van Decker
Division of Cardiology, Temple University School of Medicine, Philadelphia, Pennsylvania, USA.

Several contrast agents have been approved in the United States for radiographic imaging purposes. Most of the older ionic, high-osmolar contrast agents are no longer used because of their side effect profile. Therefore, newer nonionic, low or iso-osmolar contrast agents have been widely accepted as an alternative due to their improved tolerability and safety. We investigated the thrombogenicity of the 6 different nonionic radiocontrast media in terms of their platelet reactivity and noted some minor differences among them. In the 50% contrast concentration group, all of the nonionic contrast agents inhibited aggregation, whereas in the 10% contrast concentration group, all agents showed similar aggregation curves in comparison to the normal control. At 50% contrast concentration, the inhibitory effect of aggregation appeared to be related to the inhibition of calcium mobilization, which may be one of the mechanistic effects.

UI MeSH Term Description Entries
D007472 Iohexol An effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality. Compound 545,Exypaque,Iohexol 350,Nycodenz,Omnipaque
D007479 Iopamidol A non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiological procedures. B-15,000,B-15000,Gastromiro,Iopamidol, (+-)-Isomer,Iopamidol, (R)-Isomer,Iopamidol, Sodium Salt, (S)-Isomer,Iopamiro,Isovue,Isovue 370,Jopamidol,Niopam,SQ 13,396,Solutrast,Solutrast 370,Solutrast Gastro,B 15,000,B 15000,B15,000,B15000
D010974 Platelet Aggregation The attachment of PLATELETS to one another. This clumping together can be induced by a number of agents (e.g., THROMBIN; COLLAGEN) and is part of the mechanism leading to the formation of a THROMBUS. Aggregation, Platelet
D001792 Blood Platelets Non-nucleated disk-shaped cells formed in the megakaryocyte and found in the blood of all mammals. They are mainly involved in blood coagulation. Platelets,Thrombocytes,Blood Platelet,Platelet,Platelet, Blood,Platelets, Blood,Thrombocyte
D003287 Contrast Media Substances used to allow enhanced visualization of tissues. Radiopaque Media,Contrast Agent,Contrast Agents,Contrast Material,Contrast Materials,Radiocontrast Agent,Radiocontrast Agents,Radiocontrast Media,Agent, Contrast,Agent, Radiocontrast,Agents, Contrast,Agents, Radiocontrast,Material, Contrast,Materials, Contrast,Media, Contrast,Media, Radiocontrast,Media, Radiopaque
D003328 Coronary Thrombosis Coagulation of blood in any of the CORONARY VESSELS. The presence of a blood clot (THROMBUS) often leads to MYOCARDIAL INFARCTION. Thrombosis, Coronary,Coronary Thromboses,Thromboses, Coronary
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D006328 Cardiac Catheterization Procedures in which placement of CARDIAC CATHETERS is performed for therapeutic or diagnostic procedures. Catheterization, Cardiac,Catheterization, Heart,Heart Catheterization,Cardiac Catheterizations,Catheterizations, Cardiac,Catheterizations, Heart,Heart Catheterizations
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor

Related Publications

Alexander Georgakis, and Rasih Atilla Ener, and Jianguo Jin, and Satya Kunapuli, and David Fiss, and Stephen H Leech, and Nelson M Wolf, and William A Van Decker
A comparison of nonionic, low-osmolality radiocontrast agents with ionic, high-osmolality agents during cardiac catheterization.
February 1992, The New England journal of medicine,
Alexander Georgakis, and Rasih Atilla Ener, and Jianguo Jin, and Satya Kunapuli, and David Fiss, and Stephen H Leech, and Nelson M Wolf, and William A Van Decker
Differential effects of radiocontrast agents on human umbilical vein endothelial cells: cytotoxicity and modulators of thrombogenicity.
November 2001, European journal of medical research,
Alexander Georgakis, and Rasih Atilla Ener, and Jianguo Jin, and Satya Kunapuli, and David Fiss, and Stephen H Leech, and Nelson M Wolf, and William A Van Decker
Radiocontrast agents and aspirin.
March 1972, JAMA,
Alexander Georgakis, and Rasih Atilla Ener, and Jianguo Jin, and Satya Kunapuli, and David Fiss, and Stephen H Leech, and Nelson M Wolf, and William A Van Decker
[Radiocontrast agents: wrongfully accused?]
January 2018, Therapeutische Umschau. Revue therapeutique,
Alexander Georgakis, and Rasih Atilla Ener, and Jianguo Jin, and Satya Kunapuli, and David Fiss, and Stephen H Leech, and Nelson M Wolf, and William A Van Decker
Pharmacokinetics of iohexol, a new nonionic radiocontrast agent, in humans.
July 1984, Journal of pharmaceutical sciences,
Alexander Georgakis, and Rasih Atilla Ener, and Jianguo Jin, and Satya Kunapuli, and David Fiss, and Stephen H Leech, and Nelson M Wolf, and William A Van Decker
[Pleural extravasation of radiocontrast agents].
March 2021, La Revue du praticien,
Alexander Georgakis, and Rasih Atilla Ener, and Jianguo Jin, and Satya Kunapuli, and David Fiss, and Stephen H Leech, and Nelson M Wolf, and William A Van Decker
Anaphylactoid reactions to radiocontrast agents.
October 2001, Pediatrics in review,
Alexander Georgakis, and Rasih Atilla Ener, and Jianguo Jin, and Satya Kunapuli, and David Fiss, and Stephen H Leech, and Nelson M Wolf, and William A Van Decker
Potential thrombogenicity of angiographic contrast agents.
October 1991, Thrombosis research,
Alexander Georgakis, and Rasih Atilla Ener, and Jianguo Jin, and Satya Kunapuli, and David Fiss, and Stephen H Leech, and Nelson M Wolf, and William A Van Decker
Prevention of nephrotoxicity induced by radiocontrast agents.
November 1994, The New England journal of medicine,
Alexander Georgakis, and Rasih Atilla Ener, and Jianguo Jin, and Satya Kunapuli, and David Fiss, and Stephen H Leech, and Nelson M Wolf, and William A Van Decker
Radiocontrast agents are contact activators of coagulation.
July 1989, The British journal of radiology,
Copied contents to your clipboard!